Presbyopia Market to Grow at a Substantial Growth Rate During the Forecast Period 2032 – DelveInsight | Key Companies – Allergan, Novartis, Eyenovia, AbbVie, Regeneron, Amgen, Novartis, and Ocuphire

Delveinsight Business Research LLP
DelveInsight’s “Presbyopia Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology as well as the Presbyopia Market Size and Share in the 7MM (i.e. the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

The Presbyopia market report covers emerging drugs, current treatment practices, market share of the individual therapies, current and forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

Presbyopia: An Overview

Presbyopia is defined as the gradual loss of near-focusing ability that occurs with age. This typically comes on between the ages of 40 and 60 as the lenses of the eyes naturally lose elasticity due to the aging process. Presbyopia can be classified by type which includes incipient presbyopia, functional presbyopia, absolute presbyopia, premature presbyopia, and nocturnal presbyopia.

Presbyopia cannot be prevented. It is an inevitable part of aging. However, people who do a lot of close visual work, such as working with a computer or intensive reading, may develop presbyopia earlier than others.

As per the study Bourne et al. (2018), the crude prevalence of presbyopia was 18.94% in 2015, and women were more likely to be blind or MSVI than men.

Presbyopia Market Key Facts

The highest number of prevalent cases of Presbyopia were recorded in the United States with 117,369,600+ cases in the year 2020.

The total prevalent cases of Presbyopia were 134,726,400+ in EU-5 in 2020.

In Japan, the total number of prevalent cases of Presbyopia was 34,897,900+ in the year 2020.

According to DelveInsight’s analysis, females are affected more as compared to males, in the case of Presbyopia.

As per the study conducted by Zebardast et al. (2016), 13.6% of participants in the study had PNVI with 25.9% reporting concurrent FNVI. The study also mentioned that while the majority of participants with PNVI (82.9%) had normal distance-vision or uncorrected refractive error, less than half (46.1%) used near-vision correction. 

Presbyopia Market

The Presbyopia Market Size is anticipated to increase owing to the rise in the prevalent cases of Presbyopia during the forecast period.

The market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Presbyopia market size by analyzing the impact of current and emerging therapies in the market. It also provides a detailed assessment of the market drivers & barriers, unmet needs, and emerging technologies.

The report gives a thorough detail of the Presbyopia market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MoA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.

Presbyopia Epidemiology

The epidemiology section covers insights about the historical and current Presbyopia patient pool and forecasted trends for every seven major countries (7MM)  from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.  

Presbyopia Epidemiology Segmentation

Total Diagnosed Cases of Presbyopia

Total Prevalent Cases of Presbyopia

Gender-specific Cases of Presbyopia

Total Age-specific Cases of Presbyopia

Total Treated cases of Presbyopia

Presbyopia Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Presbyopia market or expected to get launched in the market during the study period. The analysis covers Presbyopia market uptake by drugs; patient uptake by therapies; and sales of each drug. 

Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The report also covers the Presbyopia Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II, and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses the recent Development such as collaborations, acquisitions, and mergers, licensing patent details, and other information for emerging therapies.

Presbyopia Therapeutics Analysis

A variety of options are available for optical correction of presbyopia, and the optometrist makes recommendations based on the patient’s specific vocational and avocational needs. The goal of treatment is to compensate for the inability of the eyes to focus on nearby objects. Treatment options include wearing corrective eyeglasses (spectacle lenses) or contact lenses, undergoing refractive surgery, or getting lens implants for presbyopia.

Several types of surgery are available and new techniques and technologies are making them safer and more effective. Refractive surgical procedures include Conductive Keratoplasty, LASIK, LASEK, and Photorefractive Keratectomy.

As per DelveInsight, the dynamics of the Presbyopia market is anticipated to change in the coming years owing to the emerging pipeline, growth in healthcare spending, and the rising awareness about Presbyopia across the world.

Get the PDF Sample of the Report:-

Some of the key Companies in the Presbyopia market include:








Ocuphire Pharma

And many others.

Presbyopia Drugs Covered in the Report Include:


MicroLine (Pilocarpine Ophthalmic)

PresbiDrops (CSF-1)

UNR844 (Lipoic acid cholineester)

Nyxol (Phentolamine Mesylate)

VTI-001 (Brimochol)


And many more.

Get More Detailed Insights into the Emerging Therapies & Key Companies:-

Table of Content

1. Key Insights

2. Executive Summary 

3. Presbyopia Competitive Intelligence Analysis

4. Presbyopia Market Overview at a Glance

5. Presbyopia Disease Background and Overview

6. Presbyopia Patient Journey

7. Presbyopia Epidemiology and Patient Population

8. Presbyopia Treatment Algorithm, Current Treatment, and Medical Practices

9. Presbyopia Unmet Needs

10. Key Endpoints of Presbyopia Treatment

11. Presbyopia Marketed Products

12. Presbyopia Emerging Therapies

13. Presbyopia Seven Major Market Analysis

14. Attribute Analysis

15. Presbyopia Market Outlook (7 major markets)

16. Presbyopia Access and Reimbursement Overview

17. KOL Views on the Presbyopia Market.

18. Presbyopia Market Drivers

19. Presbyopia Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The table of contents is not exhaustive; the final content may vary. 

Request Sample Report here:-

Trending Healthcare Reports By DelveInsight

Bacterial (Pyogenic) Meningitis Market

DelveInsight’s “Bacterial (Pyogenic) Meningitis Market” research report delivers an in-depth understanding of the historical and forecasted epidemiology, Bacterial (Pyogenic) Meningitis market size, share, trends, emerging therapies, and key companies operating in the market.

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States